Pharmaceutical company Novartis is laying off more than 400 employees at its East Hanover facility as part of a restructuring ...

Topline results from Phase 3 ICONIC-ADVANCE 1&2�studies show icotrokinra achieved co-primary endpoints and showed superiority to deucravacitinib in moderate-to-severe plaque PsO ...

But the shingles studies published in 2024, along with a host of new papers, add weight to an alternative decades-old ...

Never one for pomp and ceremony, the patent plaque currently resides on the wall behind the washing machine in the basement. Fishing poles, golf clubs, bowling balls, and tennis racquets were freq ...

The giving and recognition go beyond fake money, though. Employees are allowed to give coworker bonuses of $50 per month when ...

Vaccination against shingles may reduce dementia risk, suggesting viral infections play a crucial role in Alzheimer’s disease ...

Standout combination of complete skin clearance and favorable safety profile in a once daily pill could shift treatment paradigm Nearly half of patients with moderate-to-severe ...

Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for ...

Lantheus Holdings, Inc.'s stock soars 55%, fueled by Pylarify and strategic acquisitions in Alzheimer's and oncology. Click ...

Johnson & Johnson sued Samsung Bioepis for allegedly breaching a contract agreement over its launch of a biosimilar to ...

Marketers have promoted Hawaii’s natural beauty and culture for decades: erupting volcanoes, rainbows, luau, surfing, ...

and moderate to severe plaque psoriasis. Last year's global sales for Cosentyx reached $6.141 billion (Hanwha 8.6 trillion won), and the substance patent will expire in the U.S. in January 2029 ...